BIOPHARMA AS

1664 ROLVSØY

Finances

Share Ownership

Return on Equity

25,62 %

Current Ratio

1,33

Debt-to-Equity Ratio

0,51

Key figures (NOK)	2022	2021	2020	2019
Revenue	26 984 000	26 131 000	31 449 000	34 431 000
Net Income	681 000	2 871 000	3 677 000	5 691 000
Total Assets	16 293 000	15 149 000	11 203 000	14 960 000
Total Equity	2 658 000	1 443 000	1 572 000	895 000

Income (NOK)	2022	2021	2020	2019
Revenue	26 984 000	26 131 000	31 449 000	34 431 000
Expenditure	26 591 000	22 607 000	26 642 000	27 280 000
Operating Profit	732 000	3 657 000	4 678 000	7 308 000
Financial Income	141 000	24 000	32 000	32 000
Financial Costs	0	0	0	43 000
Financial Balance	141 000	24 000	32 000	−11 000
Earnings Before Tax	873 000	3 681 000	4 711 000	7 297 000
Tax	192 000	810 000	1 034 000	1 606 000
Net Income	681 000	2 871 000	3 677 000	5 691 000

Balance (NOK)	2022	2021	2020	2019
Total Fixed Assets	0	0	0	0
Total Current Assets	16 293 000	15 149 000	11 203 000	14 960 000
Total Assets	16 293 000	15 149 000	11 203 000	14 960 000
Total Retained Equity	0	138 000	267 000	−410 000
Total Equity	2 658 000	1 443 000	1 572 000	895 000
Total Long-Term Debt	1 368 000	1 710 000	2 137 000	2 671 000
Total Current Debt	12 268 000	11 997 000	7 494 000	11 393 000
Total Equity and Debt	16 293 000	15 149 000	11 203 000	14 960 000

Cash flow (NOK)	2022	2021	2020	2019
Sales Income	26 646 000	26 131 000	31 449 000	34 431 000
Other Income	338 000	0	0	0
Revenue	26 984 000	26 131 000	31 449 000	34 431 000
Cost of Goods Sold	20 164 000	15 233 000	18 794 000	19 258 000
Salary Costs	5 771 000	6 716 000	7 221 000	7 421 000
Depreciation	0	0	0	0
Impairment	0	0	0	0
Expenditure	26 591 000	22 607 000	26 642 000	27 280 000
Operating Profit	732 000	3 657 000	4 678 000	7 308 000
Financial Income	141 000	24 000	32 000	32 000
Financial Costs	0	0	0	43 000
Financial Balance	141 000	24 000	32 000	−11 000
Dividends	0	3 000 000	3 000 000	0
Net Income	681 000	2 871 000	3 677 000	5 691 000

Balance details (NOK)	2022	2021	2020	2019
Goodwill	0	0	0	0
Total Intangible Assets	0	0	0	0
Real Eastate	0	0	0	0
Machinery and Plant Facilities	0	0	0	0
Fixtures	0	0	0	0
Total Tangible Assets	0	0	0	0
Total Fiancial Fixed Assets	0	0	0	0
Total Fixed Assets	0	0	0	0
Stock	886 000	546 000	413 000	542 000
Total Investments	0	0	0	0
Cash, Bank	167 000	208 000	8 026 000	3 806 000
Total Current Assets	16 293 000	15 149 000	11 203 000	14 960 000
Total Assets	16 293 000	15 149 000	11 203 000	14 960 000
Total Equity	2 658 000	1 443 000	1 572 000	895 000
Short-Term Group Debt	0	0	0	9 595 000
Total Long-Term Debt	1 368 000	1 710 000	2 137 000	2 671 000
Creditors	3 997 000	5 823 000	138 000	129 000
Unpaid Taxes	609 000	744 000	709 000	830 000
Dividends	0	3 000 000	3 000 000	0
Other Current Debt	7 662 000	1 192 000	2 079 000	677 000
Total Current Debt	12 268 000	11 997 000	7 494 000	11 393 000
Total Equity and Debt	16 293 000	15 149 000	11 203 000	14 960 000

Financial indicators	2022	2021	2020	2019
Return on Equity	25,62 %	198,96 %	233,91 %	635,87 %
Debt-to-Equity Ratio	0,51	1,19	1,36	2,98
Operating Profit Margin	2,71 %	13,99 %	14,87 %	21,23 %
Current Ratio	1,33	1,26	1,49	1,31
Quick Ratio	1,43	1,32	1,58	1,38
Equity Ratio	0,16	0,1	0,14	0,06
Gross Profit Margin	25,27 %	41,71 %	40,24 %	44,07 %